Author:
M.D. Michele Follen,Meyskens Frank L.,Atkinson E. Neely,Schottenfeld David
Reference53 articles.
1. Bartsch D, Boye B, Baust C, et al. Retinoic acid-mediated repression of human papillomavirus 18 transcription and different ligand regulation of the retinoic acid receptor beta gene in non-tumorigenic and tumorigenic HeLa hybrid cells. EMBO J 1992; 11:2283–91.
2. Batova A, Danielpour D, Pirisi L, et al. Retinoic acid induces secretion of latent transforming growth factor ß1 and ß2 in normal and human papillomavirus type 16-immortalized human keratinocytes. Cell Growth Differ 1992;3:763–72.
3. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637–9.
4. Bell MC, Crowley-Nowick P, Bradlow HL, et al. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol 2000;78:123–9.
5. Boone C, Kelloff G, Malone W. Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: a review. Cancer Res 1990; 50:2–9.